Pharma Journalist 9023 posts 0 comments

Bristol Myers Squibb announced that Opdualag (nivolumab and relatlimab-rmbw), a new,  first-in-class, fixed-dose combination of nivolumab and relatlimab, administered as a single…
Read More...

Centogene N.V. a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced an expansion of the Company’s data…
Read More...

On March 18, 2022, Lynk Pharmaceuticals Co., Ltd. and Simcere announced a strategic partnership to develop and commercialize a highly selective JAK1 inhibitor LNK01001 in China.…
Read More...

Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, and Brookline Capital…
Read More...

SMi Group reports: ahead of the Pain Therapeutics Conference, SMi Group caught up with Andrea Small-Howard, GB Sciences Inc. SMi Group has worked with the Pain Therapeutics industry…
Read More...

Delivery Innovations in Formulation and Device Design for Enhanced Subcutaneous  Injectable Drug devices, London, UK 11th May to 12th May 2022, London, United Kingdom…
Read More...

The microbiome field is making vast breakthroughs within R&D, manufacturing, and consumer product platforms by applying live microbial consortia, engineered microbes, and…
Read More...

On May 17th, 500+ of pharma’s clinical innovation will come together for the home of clinical collaboration, Reuters Events: Pharma Clinical 2022, to set new standards in digital and…
Read More...

Cerveau Technologies, Inc. announced a research collaboration agreement with Roche Products Limited (Roche), on the use of Cerveau’s MK-6240, an investigational imaging agent, in…
Read More...

Moderna, Inc. announced that the first participant has been dosed in the Phase 2 study of the Company's Omicron-specific bivalent booster candidate (mRNA-1273.214), which combines…
Read More...